Literature DB >> 15128774

An inhibitory Ig superfamily protein expressed by lymphocytes and APCs is also an early marker of thymocyte positive selection.

Peggy Han1, Olivia D Goularte, Kevin Rufner, Beverley Wilkinson, Jonathan Kaye.   

Abstract

Positive selection of developing thymocytes is associated with changes in cell function, at least in part caused by alterations in expression of cell surface proteins. Surprisingly, however, few such proteins have been identified. We have analyzed the pattern of gene expression during the early stages of murine thymocyte differentiation. These studies led to identification of a cell surface protein that is a useful marker of positive selection and is a likely regulator of mature lymphocyte and APC function. The protein is a member of the Ig superfamily and contains conserved tyrosine-based signaling motifs. The gene encoding this protein was independently isolated recently and termed B and T lymphocyte attenuator (Btla). We describe in this study anti-BTLA mAbs that demonstrate that the protein is expressed in the bone marrow and thymus on developing B and T cells, respectively. BTLA is also expressed by all mature lymphocytes, splenic macrophages, and mature, but not immature bone marrow-derived dendritic cells. Although mice deficient in BTLA do not show lymphocyte developmental defects, T cells from these animals are hyperresponsive to anti-CD3 Ab stimulation. Conversely, anti-BTLA Ab can inhibit T cell activation. These results implicate BTLA as a negative regulator of the activation and/or function of various hemopoietic cell types.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15128774     DOI: 10.4049/jimmunol.172.10.5931

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  71 in total

1.  Evolutionarily divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathway.

Authors:  Timothy C Cheung; Ian R Humphreys; Karen G Potter; Paula S Norris; Heather M Shumway; Bonnie R Tran; Ginelle Patterson; Rochelle Jean-Jacques; Miri Yoon; Patricia G Spear; Kenneth M Murphy; Nell S Lurain; Chris A Benedict; Carl F Ware
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-30       Impact factor: 11.205

2.  A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator.

Authors:  Lino C Gonzalez; Kelly M Loyet; Jill Calemine-Fenaux; Vandana Chauhan; Bernd Wranik; Wenjun Ouyang; Dan L Eaton
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-12       Impact factor: 11.205

Review 3.  The many sounds of T lymphocyte silence.

Authors:  Ignacio Melero; Ainhoa Arina; Lieping Chen
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 4.  LIGHT-related molecular network in the regulation of innate and adaptive immunity.

Authors:  Yanhui Xu; Koji Tamada; Lieping Chen
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

5.  Targeting of antigen to the herpesvirus entry mediator augments primary adaptive immune responses.

Authors:  Marcio O Lasaro; Nia Tatsis; Scott E Hensley; J Charles Whitbeck; Shih-Wen Lin; John J Rux; E John Wherry; Gary H Cohen; Roselyn J Eisenberg; Hildegund C Ertl
Journal:  Nat Med       Date:  2008-01-13       Impact factor: 53.440

Review 6.  Regulating the mucosal immune system: the contrasting roles of LIGHT, HVEM, and their various partners.

Authors:  Marcos W Steinberg; Jr-Wen Shui; Carl F Ware; Mitchell Kronenberg
Journal:  Semin Immunopathol       Date:  2009-06-03       Impact factor: 9.623

Review 7.  Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways.

Authors:  Carl F Ware
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

8.  Development of autoimmune hepatitis-like disease and production of autoantibodies to nuclear antigens in mice lacking B and T lymphocyte attenuator.

Authors:  Yoshihiro Oya; Norihiko Watanabe; Takayoshi Owada; Mie Oki; Koichi Hirose; Akira Suto; Shin-Ichiro Kagami; Hiroshi Nakajima; Takashi Kishimoto; Itsuo Iwamoto; Theresa L Murphy; Kenneth M Murphy; Yasushi Saito
Journal:  Arthritis Rheum       Date:  2008-08

Review 9.  Mechanisms of Resistance to PD-1 Checkpoint Blockade.

Authors:  Justin C Moser; Siwen Hu-Lieskovan
Journal:  Drugs       Date:  2020-04       Impact factor: 9.546

10.  CpG-ODN-induced sustained expression of BTLA mediating selective inhibition of human B cells.

Authors:  Marie-Laure Thibult; Jean-Paul Rivals; Emilie Mamessier; Julie Gertner-Dardenne; Sonia Pastor; Daniel E Speiser; Laurent Derré; Daniel Olive
Journal:  J Mol Med (Berl)       Date:  2012-08-19       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.